VSS Capital Partners Makes Growth Investment in Eximia Research Network
October 4, 2023
VSS Capital Partners has made a growth capital investment to form and scale Eximia Research Network, a multi-therapeutic clinical research site network led by CEO Dr. Ella Grach. The investment establishes Eximia as a platform company that will leverage centralized services and a strategic partnership with Sundance Clinical Research to expand clinical trial delivery and access.
- Buyers
- VSS Capital Partners
- Targets
- Eximia Research Network
- Platforms
- Eximia Research Network
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.